Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:449

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

(Circulation. 2005;112:449.)
© 2005 American Heart Association, Inc.

Issue Highlights


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    PERCUTANEOUS VERSUS SURGICAL TREATMENT FOR PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AND ENLARGED ANTERIOR MITRAL VALVE LEAFLETS, by van der Lee et al.
 
Surgical myectomy is an accepted therapy for patients with symptomatic hypertrophic obstructive cardiomyopathy (HOCM). When this condition is accompanied by enlargement of the anterior mitral valve leaflet, combining myectomy with mitral leaflet extension reduces the postoperative aortic outflow gradient and mitral regurgitation. Percutaneous transluminal septal myocardial ablation by alcohol injection into the septal coronary arteries is emerging as an alternative treatment for HOCM. In this issue of Circulation, van der Lee and colleagues compared outcome after percutaneous ablation in 43 patients with HOCM and enlargement of the anterior mitral valve leaflet to the outcomes of 29 historical control patients who were treated surgically. The authors report that percutaneous treatment is associated with more periprocedural complications and greater need for a second intervention, providing evidence that the surgical approach might be preferred in such patients. See p 482.


*    ELEVATED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS ARE PROTECTIVE AGAINST PLAQUE PROGRESSION: A FOLLOW-UP STUDY OF 1952 PERSONS WITH CAROTID ATHEROSCLEROSIS: THE TROMSØ STUDY, by Johnson et al.
 
Carotid intimal medial thickness and carotid plaques are important markers of subclinical atherosclerosis. Whereas studies have evaluated cross-sectional relations of carotid plaques, data on correlates of plaque progression/growth are lacking. In this issue of Circulation, Johnsen and colleagues performed serial carotid ultrasonography on participants in the community-based Tromso Study. The investigators evaluated determinants of change in the size (area) and echogenicity of carotid plaques prospectively. Higher age, systolic blood pressure, and smoking and lower high-density lipoprotein (HDL) cholesterol were key correlates of plaque growth. Additionally, greater plaque echogenicity at baseline was associated with less growth over time. Thus, the study demonstrates the feasibility of assessing carotid plaque growth and changes . . . [Full Text of this Article]